2Gum PA, Kottke-Marchan K, Poggio ED, Topol EJ. Profile and prevalence of aspirin resistance in patients with cardiovascular disease.Am J Cardiol,2001,88:230-5.
3Friend M, Vucenik I,Miller M.platelet responsiveness to aspirin in patients with hyperlipidaemia[J].BMJ,2003,326:82-3.
4Sane DC, McKee SA, Malinin AI,Serebruany VL.Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin[J].Am J Cardiol,2002,90:893-5.
5Buchanan MR,Brister SJ.individual variation in the effects of ASA on platelet function implications for the use of ASA clinically[J].Can J Cardiol,1995,11:221-7.
6Gum PA, Kottke-Marchan K, Weish PA,Topol EJ.A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. Am J Cardiol 2003,41:961-5.
7Muller MR,Salat A, Stangle P, murabito M, Pulaki S,Boehm D. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty[J].Thromb Haemost,1997,78:1003-7.
8Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q,Yusuf S.Aspirin-resistance thromboxane biosynthesis and the risk of myocardial infarction, stroke or cardiovascular death in patients of aspirin resistance in patients with cardiovascular events[J].Circulation,2002,105:1650-5.
9Hung J, Lam JYT, Letchavobski G. Cigarette smoking cutely increase platelet thrombus formation in patients with coronary artery disease taking aspirin[J].Ciuculaiton,1995,92:2432-6.
10Catella-Lawson F, Reilly MP, Kapoor SC, Vyas SN, FitzGerald GA.Cyclooxygenase inhibitors and the antiplatelet effects of aspirin[J].N Eng J Med,2001,345(25):1809-45.
